查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1820180

疫苗合約製造市場報告，按疫苗類型（減毒疫苗、去活化疫苗、亞單位疫苗、類毒素疫苗、DNA疫苗）、工作流程（下游、上游）、應用（人類使用、獸醫）和地區分類，2025 年至 2033 年

Vaccine Contract Manufacturing Market Report by Vaccine Type (Attenuated, Inactivated, Subunit-based, Toxoid-based, DNA-based), Workflow (Downstream, Upstream), Application (Human Use, Veterinary), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2024年全球疫苗合約製造市場規模達30億美元。展望未來， IMARC Group預計到2033年市場規模將達到63億美元，2025-2033年期間的成長率（CAGR）為8.45%。

疫苗合約生產是指將大規模疫苗生產外包給合約生產組織 (CMO)。這些組織提供多種服務，包括預製劑工作、製劑開發、方法開發、穩定性研究、臨床前活動、註冊批次和商業化生產。此外，他們還提供專業知識和創新技術，以擴展製藥公司的生產鏈。目前，由於開發成本降低和生產方案複雜度降低，全球對疫苗生產活動外包的需求正在不斷成長。

疫苗接種在改善人類和動物健康方面發揮關鍵作用。它減少了對抗生素的需求並預防疾病。人們對疫苗接種及其許多相關益處（例如預防重症和傳染病）的認知日益提高，這刺激了對免疫接種計劃和疫苗接種的需求。由於對生產資本需求複雜性的理解，領先的製藥公司將疫苗生產外包。此外，資源匱乏的國家缺乏疫苗生產設備和熟練勞動力，也助長了全球疫苗合約生產市場的成長。此外，包括EB66和GPEx等表達系統以及細胞培養基平台的引入在內的技術進步正在支持市場成長。此外，許多國家冠狀病毒病（COVID-19）病例的驚人成長促使疫苗開發商與合約生產企業（CMO）簽署了外包協議。這為市場的成長創造了良好的前景。

本報告回答的關鍵問題

  • 疫苗合約生產市場有多大？疫苗合約生產市場未來前景如何？
  • 推動疫苗合約製造市場的關鍵因素有哪些？
  • 全球疫苗合約製造市場領先的公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球疫苗合約製造市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依疫苗類型

  • 減毒
  • 去活化
  • 基於亞基
  • 基於類毒素
  • 基於DNA

第7章：市場區隔：依工作流程

  • 下游
    • 關鍵部分
      • 填充和完成操作
      • 分析和品質控制研究
      • 包裝
  • 上游
    • 關鍵部分
      • 哺乳動物表達系統
      • 細菌表現系統
      • 酵母表現系統
      • 桿狀病毒/昆蟲表現系統
      • 其他

第 8 章：市場區隔：按應用

  • 人類使用
  • 獸醫

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 10 章：SWOT 分析

第 11 章：價值鏈分析

第 12 章：波特五力分析

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Ajinomoto Co. Inc.
    • Albany Molecular Research Inc
    • Catalent Inc
    • Cobra Biologics Limited (Charles River Laboratories International Inc.)
    • Cytovance Biologics Inc. (Hepalink USA Inc.)
    • Fujifilm Holdings Corporation
    • ICON plc
    • IDT Biologika GmbH
    • Lonza Group AG
    • Merck KGaA
    • Pharmaceutical Product Development LLC
    • PRA Health Sciences Inc.
Product Code: SR112025A3872

The global vaccine contract manufacturing market size reached USD 3.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.3 Billion by 2033, exhibiting a growth rate (CAGR) of 8.45% during 2025-2033.

Vaccine contract manufacturing refers to the outsourcing of large-scale production of vaccines to contract manufacturing organizations (CMOs). These organizations offer numerous services, including pre-formulation work, formulation development, method development, stability studies, pre-clinical activities, registration batches and commercial manufacturing. Apart from this, they provide expertise and innovative technologies to expand the production chain of pharmaceutical companies. At present, the demand for outsourcing vaccine manufacturing activities is escalating worldwide on account of reduced development costs and complex production protocols.

Vaccination plays a pivotal role in improving human as well as veterinary health. It reduces the need for antibiotics and prevents diseases. The increasing awareness about vaccination and numerous associated benefits, such as protection from severe illnesses and infectious diseases, is catalyzing the demand for immunization programs and inoculations. This, in confluence with understanding the complexity of capital requirement for production, has led the leading pharmaceutical companies to outsource vaccine manufacturing. Apart from this, the lack of equipment and skilled labor for vaccine production in low-resource countries is also contributing to the global vaccine contract manufacturing market growth. Moreover, technological advancements, including the introduction of expression systems like the EB66 and GPEx and cell culture media platforms, are supporting the market growth. Furthermore, the alarmingly growing cases of coronavirus disease (COVID-19) in numerous countries have propelled the vaccine developers to sign outsourcing agreements with CMOs. This is creating a favorable outlook for the growth of the market.

Key Market Segmentation:

Breakup by Vaccine Type:

  • Attenuated
  • Inactivated
  • Subunit-based
  • Toxoid-based
  • DNA-based

Breakup by Workflow:

  • Downstream
    • Fill and Finish Operations
    • Analytical and QC Studies
    • Packaging
  • Upstream
    • Mammalian Expression Systems
    • Bacterial Expression Systems
    • Yeast Expression Systems
    • Baculovirus/Insect Expression Systems
    • Others

Breakup by Application:

  • Human Use
  • Veterinary

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Ajinomoto Co. Inc., Albany Molecular Research Inc, Catalent Inc, Cobra Biologics Limited (Charles River Laboratories International Inc.), Cytovance Biologics Inc. (Hepalink USA Inc.), Fujifilm Holdings Corporation, ICON plc, IDT Biologika GmbH, Lonza Group AG, Merck KGaA, Pharmaceutical Product Development LLC and PRA Health Sciences Inc.

Key Questions Answered in This Report

  • 1.How big is the vaccine contract manufacturing market?
  • 2.What is the future outlook of vaccine contract manufacturing market?
  • 3.What are the key factors driving the vaccine contract manufacturing market?
  • 4.Which are the leading companies in the global vaccine contract manufacturing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Vaccine Contract Manufacturing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Vaccine Type

  • 6.1 Attenuated
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Inactivated
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Subunit-based
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Toxoid-based
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 DNA-based
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Workflow

  • 7.1 Downstream
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Fill and Finish Operations
      • 7.1.2.2 Analytical and QC studies
      • 7.1.2.3 Packaging
    • 7.1.3 Market Forecast
  • 7.2 Upstream
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Mammalian Expression Systems
      • 7.2.2.2 Bacterial Expression Systems
      • 7.2.2.3 Yeast Expression Systems
      • 7.2.2.4 Baculovirus/Insect Expression Systems
      • 7.2.2.5 Others
    • 7.2.3 Market Forecast

8 Market Breakup by Application

  • 8.1 Human Use
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Veterinary
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Ajinomoto Co. Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Albany Molecular Research Inc
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Catalent Inc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Cobra Biologics Limited (Charles River Laboratories International Inc.)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Cytovance Biologics Inc. (Hepalink USA Inc.)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Fujifilm Holdings Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 ICON plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 IDT Biologika GmbH
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Lonza Group AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Merck KGaA
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Pharmaceutical Product Development LLC
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 PRA Health Sciences Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials

List of Figures

  • Figure 1: Global: Vaccine Contract Manufacturing Market: Major Drivers and Challenges
  • Figure 2: Global: Vaccine Contract Manufacturing Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Vaccine Contract Manufacturing Market: Breakup by Vaccine Type (in %), 2024
  • Figure 5: Global: Vaccine Contract Manufacturing Market: Breakup by Workflow (in %), 2024
  • Figure 6: Global: Vaccine Contract Manufacturing Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Vaccine Contract Manufacturing Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Vaccine Contract Manufacturing (Attenuated) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Vaccine Contract Manufacturing (Attenuated) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Vaccine Contract Manufacturing (Inactivated) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Vaccine Contract Manufacturing (Inactivated) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Vaccine Contract Manufacturing (Subunit-based) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Vaccine Contract Manufacturing (Subunit-based) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Vaccine Contract Manufacturing (Toxoid-based) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Vaccine Contract Manufacturing (Toxoid-based) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Vaccine Contract Manufacturing (DNA-based) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Vaccine Contract Manufacturing (DNA-based) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Vaccine Contract Manufacturing (Downstream) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Vaccine Contract Manufacturing (Downstream) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Vaccine Contract Manufacturing (Upstream) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Vaccine Contract Manufacturing (Upstream) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Vaccine Contract Manufacturing (Human Use) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Vaccine Contract Manufacturing (Human Use) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Vaccine Contract Manufacturing (Veterinary) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Vaccine Contract Manufacturing (Veterinary) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia-Pacific: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia-Pacific: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Vaccine Contract Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Vaccine Contract Manufacturing Market: Breakup by Country (in %), 2024
  • Figure 74: Middle East and Africa: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Global: Vaccine Contract Manufacturing Industry: SWOT Analysis
  • Figure 76: Global: Vaccine Contract Manufacturing Industry: Value Chain Analysis
  • Figure 77: Global: Vaccine Contract Manufacturing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Vaccine Contract Manufacturing Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Vaccine Type (in Million USD), 2025-2033
  • Table 3: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Workflow (in Million USD), 2025-2033
  • Table 4: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Vaccine Contract Manufacturing Market: Competitive Structure
  • Table 7: Global: Vaccine Contract Manufacturing Market: Key Players